TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33431281

Group type: EXPERIMENTAL
Intervention: Ischemic compression (90 seconds over each TrP)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 29
Study: 32514005

Group type: EXPERIMENTAL
Intervention: Low-caloric diet (LCD, 800 kcal/d for 8 weeks)
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Plasma omics model based on baseline parameters
Number of subjects: 375
Study: 33119180

Group type: EXPERIMENTAL
Intervention: Vergence/accommodative therapy
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 115
Study: 33126096

Group type: EXPERIMENTAL
Intervention: Training healthcare workers as change agents in a Social and Behavioural Change Communication workshop, supported by a social marketing campaign.
Number of subjects: 652

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 652
Study: 33586090

Group type: EXPERIMENTAL
Intervention: 0.01% atropine eye drops
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 171
Study: 32941094

Group type: EXPERIMENTAL
Intervention: Air abrasion with silica‐coated 30‐m Al2O3 particles (Groups 2 & 6)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Air abrasion with universal primer (Groups 3 & 7)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Air abrasion with universal adhesive (Groups 4 & 8)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Activa (Groups 6 & 8)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Bulk‐fill flowable resin‐based composite (Bulk‐RBC) (Groups 1‐4)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control without surface treatment (Groups 1 & 5)
Number of subjects: 240
Study: 33000478

Group type: EXPERIMENTAL
Intervention: Additional 10 minutes of 1-on-1 instruction by a trained physical therapy student or dental faculty member
Number of subjects: 41
Study: 35672926

Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon beta‐1a (IFNβ1a) / placebo
Number of subjects: 0
Study: 35452688

Group type: COMPARATOR
Intervention: Intravenous infusion amiodarone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Oral propafenone
Number of subjects: 200
Study: 33666322

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Virtual Reality Exposure (VRE)
Number of subjects: 61
Study: 35090799

Group type: EXPERIMENTAL
Intervention: Sodium nitrate (NaNO3) supplementation for 8 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 34204415

Group type: EXPERIMENTAL
Intervention: Low-intensity percutaneous electrolysis (0.3 mA × 90 s)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: High-intensity percutaneous electrolysis (three bouts of 3 mA × 3 s)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Needling intervention without electrical current
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Low-intensity percutaneous electrolysis
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: High-intensity percutaneous electrolysis
Number of subjects: 72
Study: 35082960

Group type: EXPERIMENTAL
Intervention: Breathing exercise using bubble blower (BE) + Inferior Alveolar Nerve Block (IANB)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Routine Inferior Alveolar Nerve Block (IANB)
Number of subjects: 35
Study: 33630179

Group type: EXPERIMENTAL
Intervention: Low time pressure (10-s time per trial)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High time pressure (5-s time per trial)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Automation support (85% reliability)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High time pressure in target-absent trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Target expectancy (predictable location of targets)
Number of subjects: 0
Study: 36254693

Group type: EXPERIMENTAL
Intervention: empagliflozin 10 mg once daily
Number of subjects: 530

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 530
Study: 34411217

Group type: EXPERIMENTAL
Intervention: Flapless guided surgery
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional flap surgery
Number of subjects: 10
Study: 33216773

Group type: EXPERIMENTAL
Intervention: Home-based HIV testing services (HBHTS)
Number of subjects: 1000
Study: 36459908

Group type: EXPERIMENTAL
Intervention: Topical olive oil dressing plus standard care (wound irrigation with normal saline and oral antibiotics) for four weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 60
Study: 33454241

Group type: EXPERIMENTAL
Intervention: APOB mutation carriers (n=40, LDL-C ≤ 50 mg/dL)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Wild-type controls (n=40, LDL-C ≤ 50 mg/dL)
Number of subjects: 120
Study: 35802811

Group type: EXPERIMENTAL
Intervention: Moderate exercise (45 minutes)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Vigorous exercise (30 minutes)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 56
Study: 33559358

Group type: EXPERIMENTAL
Intervention: Microcurrent application to the heart
Number of subjects: 10
Study: 34807713

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 4796

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4796
Study: 35724585

Group type: EXPERIMENTAL
Intervention: Economic support
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Combined economic support, CSE and community dialogue
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: CSE and community dialogue
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control
Number of subjects: 157
Study: 35934006

Group type: EXPERIMENTAL
Intervention: Boost after whole breast irradiation (WBI)
Number of subjects: 1608

Group type: COMPARATOR
Intervention: No boost after whole breast irradiation (WBI)
Number of subjects: 1608

Group type: EXPERIMENTAL
Intervention: Boost after conventional WBI (50 Gy in 25 fractions)
Number of subjects: 1608

Group type: COMPARATOR
Intervention: No boost after conventional WBI (50 Gy in 25 fractions)
Number of subjects: 1608

Group type: EXPERIMENTAL
Intervention: Boost after hypofractionated WBI (42.5 Gy in 16 fractions)
Number of subjects: 1608

Group type: COMPARATOR
Intervention: No boost after hypofractionated WBI (42.5 Gy in 16 fractions)
Number of subjects: 1608
Study: 33733893

Group type: EXPERIMENTAL
Intervention: Liquefied petroleum gas (LPG) stove and 18-month supply of free fuel
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Visual messages to support LPG use
Number of subjects: 3200
Study: 35325020

Group type: EXPERIMENTAL
Intervention: BABEL approach to advance care planning (structured discussion of ~60 minutes)
Number of subjects: 713

Group type: COMPARATOR
Intervention: Usual advance care planning processes in control NHs
Number of subjects: 713
Study: 36066851

Group type: EXPERIMENTAL
Intervention: Alpelisib plus Olaparib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-care chemotherapy
Number of subjects: 0
Study: 33793110

Group type: EXPERIMENTAL
Intervention: Acupuncture plus medication (tamsulosin hydrochloride 0.2 mg nightly)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Medication (tamsulosin hydrochloride 0.2 mg nightly)
Number of subjects: 70
Study: 34739450

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg/kg/hour)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Propofol (2 mg/kg/hour)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 33743263

Group type: EXPERIMENTAL
Intervention: MONO-TM
Number of subjects: 50

Group type: COMPARATOR
Intervention: MODULAR-FM
Number of subjects: 50
Study: 35074451

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 80
Study: 33221299

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (DCB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Plain old balloon angioplasty (POBA)
Number of subjects: 40
Study: 33252241

Group type: EXPERIMENTAL
Intervention: Equine-Assisted Activity (EAA) program, 40 minutes twice a week for 16 weeks (32 sessions)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 26
Study: 32330694

Group type: EXPERIMENTAL
Intervention: Teriparatide (TPTD)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 38
Study: 35220449

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 758

Group type: COMPARATOR
Intervention: Drug-eluting stent (DES)
Number of subjects: 758
Study: 34564020

Group type: EXPERIMENTAL
Intervention: Nintedanib (150 mg twice daily)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 108
Study: 34409915

Group type: EXPERIMENTAL
Intervention: Fractional Er:YAG (2940 nm) laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Long pulsed Nd:YAG (1064 nm) laser
Number of subjects: 20
Study: 36468605

Group type: EXPERIMENTAL
Intervention: Individual caregiver yoga (CY)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Dyadic yoga (DY)
Number of subjects: 67
Study: 33740344

Group type: EXPERIMENTAL
Intervention: Transforaminal (TF) cervical epidural steroid injection
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Parasagittal interlaminar (IL) cervical epidural steroid injection
Number of subjects: 80
Study: 32379118

Group type: EXPERIMENTAL
Intervention: Articulating spacer
Number of subjects: 68

Group type: COMPARATOR
Intervention: Static spacer
Number of subjects: 68
Study: 36226676

Group type: EXPERIMENTAL
Intervention: 60-min massage doses
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: 30-min massage doses
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: 15-min massage doses
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: 3×/week massage doses
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: 15-min doses
Number of subjects: 273
Study: 33570485

Group type: EXPERIMENTAL
Intervention: Clarithromycin (CAM)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Azithromycin (AZM)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: AIM MIC
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Morphological changes
Number of subjects: 49
Study: 34237699

Group type: EXPERIMENTAL
Intervention: DASH
Number of subjects: 1862

Group type: EXPERIMENTAL
Intervention: HEI‐2015
Number of subjects: 1862

Group type: EXPERIMENTAL
Intervention: MD
Number of subjects: 1862

Group type: EXPERIMENTAL
Intervention: E‐DII
Number of subjects: 1862
Study: 32067724

Group type: EXPERIMENTAL
Intervention: Rhythmically enhanced music
Number of subjects: 25

Group type: COMPARATOR
Intervention: No music
Number of subjects: 25
Study: 34491142

Group type: EXPERIMENTAL
Intervention: Frenotomy for PTT (surgical treatment arm, n = 24)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Observational/control arm (n = 23)
Number of subjects: 47
Study: 34453688

Group type: EXPERIMENTAL
Intervention: Real tDCS (1.5 mA, 20 min)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 21
Study: 34053119

Group type: EXPERIMENTAL
Intervention: Oxybutynin patch
Number of subjects: 100

Group type: COMPARATOR
Intervention: Mirabegron
Number of subjects: 100
Study: 32767766

Group type: EXPERIMENTAL
Intervention: Diclofenac potassium for oral solution (50 mg)
Number of subjects: 25
Study: 35185013

Group type: EXPERIMENTAL
Intervention: Triple-strain (TS) probiotic
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Single-strain (SS) probiotic
Number of subjects: 173

Group type: COMPARATOR
Intervention: Probiotic supplementation (PS)
Number of subjects: 173
Study: 33143164

Group type: EXPERIMENTAL
Intervention: Pemetrexed + cisplatin (PEM)
Number of subjects: 548

Group type: COMPARATOR
Intervention: Etoposide + cisplatin (ETO)
Number of subjects: 548
Study: 33657762

Group type: EXPERIMENTAL
Intervention: Neurogenic acupoint dry cupping therapy plus lifestyle modifications for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lifestyle modifications for 8 weeks
Number of subjects: 30
Study: 32489807

Group type: EXPERIMENTAL
Intervention: Very early PCI (within 3-12 hours)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Early PCI (within 12-24 hours)
Number of subjects: 420
Study: 33507394

Group type: EXPERIMENTAL
Intervention: Treated Dentin Matrix Hydrogel (TDMH)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Biodentine
Number of subjects: 45

Group type: COMPARATOR
Intervention: MTA
Number of subjects: 45
Study: 33032710

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 336

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 336
Study: 35620204

Group type: EXPERIMENTAL
Intervention: AI technology combined with ultrasound-guided needle knife interventional therapy
Number of subjects: 130
Study: 34242445

Group type: EXPERIMENTAL
Intervention: Pulsatile flow
Number of subjects: 16

Group type: COMPARATOR
Intervention: Non-pulsatile flow
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low pulsatility
Number of subjects: 16
Study: 32200533

Group type: EXPERIMENTAL
Intervention: Omega-3 at 2g (QD) for 8 weeks
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Omega-3 at 4g (2g BID) for 8 weeks
Number of subjects: 37
Study: 36215289

Group type: EXPERIMENTAL
Intervention: Gefitinib plus pemetrexed-based chemotherapy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Gefitinib alone
Number of subjects: 8
Study: 33108484

Group type: EXPERIMENTAL
Intervention: Low-concentration peptide-HAP suspension (0.5 wt% HAP; Curodont, Credentis)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-concentration peptide-HAP suspension (6.25% HAP; Curodont Protect)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Commercial bleaching agent (VivaStyle Paint on Plus, VS, Ivoclar Vivadent)
Number of subjects: 40
Study: 32597706

Group type: EXPERIMENTAL
Intervention: Ridinilazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 0
Study: 33731570

Group type: EXPERIMENTAL
Intervention: BoNT‐A (1:2.5, 1:5, 1:7.5)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 15
Study: 32753571

Group type: EXPERIMENTAL
Intervention: Full-layer barbed suture (group A)
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Barbed suturing of the joint capsule (group B)
Number of subjects: 582

Group type: COMPARATOR
Intervention: Traditional absorbable suture (group C)
Number of subjects: 582
Study: 33969750

Group type: EXPERIMENTAL
Intervention: Cladribine tablets 3.5 mg/kg
Number of subjects: 968

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 968
Study: 34167324

Group type: EXPERIMENTAL
Intervention: SPRINT trial
Number of subjects: 3048

Group type: EXPERIMENTAL
Intervention: RESTORE trial
Number of subjects: 3048
Study: 32289474

Group type: EXPERIMENTAL
Intervention: 15 day hypofractionated PMRT regimen (3.33 Gy daily to the chest wall and regional lymphatics in 11 fractions, with optional 4 fraction mastectomy scar boost)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: 15 day hypofractionated PMRT regimen
Number of subjects: 67
Study: 35502503

Group type: EXPERIMENTAL
Intervention: High-volume TFEB with steroids (group D)
Number of subjects: 54

Group type: COMPARATOR
Intervention: High-volume TFEB without steroids (group L)
Number of subjects: 54
Study: 34535170

Group type: EXPERIMENTAL
Intervention: Quality Improvement (QI) training and mentorship
Number of subjects: 209

Group type: COMPARATOR
Intervention: Standard of Care (SOC) support
Number of subjects: 209
Study: 36109422

Group type: EXPERIMENTAL
Intervention: Osc+ condition (increased heart rate oscillations)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Osc- condition (little effect on heart rate oscillations)
Number of subjects: 106
Study: 34385097

Group type: EXPERIMENTAL
Intervention: MyPEEPS Mobile app
Number of subjects: 40
Study: 32306987

Group type: EXPERIMENTAL
Intervention: Maintenance targeted therapy after chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Agents with a positive efficacy signal
Number of subjects: 0
Study: 35307550

Group type: EXPERIMENTAL
Intervention: 1 mg/kg CBD
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 3 mg/kg CBD
Number of subjects: 12
Study: 33617635

Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 35938351

Group type: EXPERIMENTAL
Intervention: Probiotic diet (Synbio® blend)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 35079596

Group type: EXPERIMENTAL
Intervention: Psychoeducation + CogRx
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Psychoeducation only
Number of subjects: 150

Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 150
Study: 32106174

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 20
Study: 35609202

Group type: EXPERIMENTAL
Intervention: Family planning intervention (FP) including up to six counseling sessions, free transportation to FP clinic, free FP services, and treatment for contraceptive-related side effects.
Number of subjects: 2143

Group type: EXPERIMENTAL
Intervention: Family planning intervention (FP)
Number of subjects: 2143
Study: 33265966

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 151
Study: 35122952

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Individual and group supportive therapy
Number of subjects: 173
Study: 33191061

Group type: EXPERIMENTAL
Intervention: High-energy flux density (H-ESWT) - 7 sessions (0.26 mJ/mm2)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: High-energy flux density (H-ESWT) - 3 sessions (0.26 mJ/mm2)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Low-energy flux density (LESWT) - 7 sessions (<0.08 mJ/mm2)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Comparison between Group 1 (H-ESWT 7 sessions) and Group 2 (H-ESWT 3 sessions)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Comparison between Group 2 (H-ESWT 3 sessions) and Group 3 (LESWT 7 sessions)
Number of subjects: 94
Study: 32771369

Group type: EXPERIMENTAL
Intervention: Computer-based decision aid
Number of subjects: 253

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 253
Study: 33924645

Group type: EXPERIMENTAL
Intervention: Vitamin D (150,000 IU) administered 24 hours before the run
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 32243043

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300)
Number of subjects: 929

Group type: COMPARATOR
Intervention: Insulin degludec 100 U/mL (IDeg-100)
Number of subjects: 929
Study: 33191598

Group type: EXPERIMENTAL
Intervention: Exposure to pro-conspiracy articles
Number of subjects: 790

Group type: EXPERIMENTAL
Intervention: Exposure to anti-conspiracy articles
Number of subjects: 790

Group type: COMPARATOR
Intervention: Control group (neutral articles)
Number of subjects: 790

Group type: EXPERIMENTAL
Intervention: Exposure to antidepressant conspiracy theories (Study 3)
Number of subjects: 790

Group type: EXPERIMENTAL
Intervention: Exploratory analysis of gender differences (Study 2)
Number of subjects: 790
Study: 36072634

Group type: EXPERIMENTAL
Intervention: Bronchial artery embolization (BAE)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 92
Study: 33245631

Group type: EXPERIMENTAL
Intervention: Mobile virtual intervention, Sister, I will tell you!©, including reflective writing and mindfulness meditation for 4 weeks.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Audio-guided mindfulness meditation (control group).
Number of subjects: 34
Study: 35975641

Group type: EXPERIMENTAL
Intervention: CT-P13
Number of subjects: 198

Group type: COMPARATOR
Intervention: Originator Infliximab
Number of subjects: 198
Study: 35118982

Group type: EXPERIMENTAL
Intervention: Biofeedback before RP
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Biofeedback after RP
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no biofeedback)
Number of subjects: 57
Study: 35466013

Group type: EXPERIMENTAL
Intervention: Radiotherapy dose escalation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic therapy optimisation
Number of subjects: 0
Study: 34449080

Group type: EXPERIMENTAL
Intervention: Dietary supplementation
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no dietary supplementation)
Number of subjects: 33
Study: 34757917

Group type: EXPERIMENTAL
Intervention: Drug-coated balloons (DCB)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Drug-eluting stents (DES)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both DCB and DES
Number of subjects: 42
Study: 34627967

Group type: EXPERIMENTAL
Intervention: High-intensity EMS (n=10)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-intensity EMS (n=9)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Controls (n=8)
Number of subjects: 27
Study: 32479786

Group type: EXPERIMENTAL
Intervention: Intravenous haloperidol dose escalation at 2 mg every 4 h
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Neuroleptic rotation with chlorpromazine at 25 mg every 4 h
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Combined haloperidol at 1 mg and chlorpromazine at 12·5 mg every 4 h
Number of subjects: 68
Study: 34562775

Group type: EXPERIMENTAL
Intervention: Lowest health literacy profile (n = 86, 15.1%)
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Moderate health literacy profile (n = 338, 59.5%)
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Highest health literacy profile (n = 144, 25.4%)
Number of subjects: 568

Group type: COMPARATOR
Intervention: Control for demographic variables
Number of subjects: 568
Study: 33037990

Group type: EXPERIMENTAL
Intervention: Once-weekly carfilzomib plus dexamethasone (Kd) 20/70 mg/m2
Number of subjects: 40

Group type: COMPARATOR
Intervention: Twice-weekly carfilzomib plus dexamethasone (Kd) 20/27 mg/m2
Number of subjects: 40
Study: 34626757

Group type: EXPERIMENTAL
Intervention: Sitting Position (SP)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Prone Position (PP)
Number of subjects: 41